About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
ASCO 2022 Conference Coverage
Breast
Lung
GI
GU
Skin
GYN
Head & Neck
Leukemia
Lymphoma
Myeloma
MDS and MPN
Sarcoma
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Taking on Goliath: Targeting KRAS in NSCLC
By
Jia Luo
2 Videos
1,177 views
June 16, 2022
This video was recorded prior to the FDA granting approval to Adagrasib (Krazati) on December
...
read more ↘
12, 2022
↖ read less
1 Comment
Login to view comments.
Click here to Login
Lung
01:24
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…
Feat.
L. Paz-Ares
10:59
ASCO 2022 Conference Coverage
ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…
Feat.
L. Paz-Ares
01:21
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L …
Feat.
F. de Marinis
12:27
ASCO 2022 Conference Coverage
ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L Pralsetinib in RET…
Feat.
F. de Marinis
01:08
ASCO 2022 Conference Coverage
Lecture Summary - Pralsetinib in Patients (pts) With Advanced or Met…
Feat.
L. Wirth
10:01
ASCO 2022 Conference Coverage
ASCO 2022 Updated Data From the ARROW Trial: Pralsetinib in Patients…
Feat.
L. Wirth
01:46
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…
Feat.
L. Paz-Ares
09:18
ASCO 2022 Conference Coverage
ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…
Feat.
L. Paz-Ares
26:58
ASCO 2022 Conference Coverage
ASCO 2022 Immunotherapy Nuances in Locally Advanced NSCLC
Feat.
J. Varlotto
48
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Immunotherapy Nuances in Locally Advance…
Feat.
J. Varlotto
06:33
ASCO 2022 Conference Coverage
ASCO 2022 on Acquired EGFR-Resistant Mutations in NSCLC
Feat.
L. Raez
55
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Acquired EGFR-Resistant Mutations in …
Feat.
L. Raez
01:06
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Recurrent SCLC: Can We Change the Par…
Feat.
R. Gentzler
01:28
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…
Feat.
B. Chul Cho
07:37
ASCO 2022 Conference Coverage
ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…
Feat.
B. Chul Cho
05:02
ASCO 2022 Conference Coverage
ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…
Feat.
L. Mazzeo,
M. Occhipinti
01:09
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Impact of Trilaciclib on Multilineage Ch…
Feat.
J. Goldschmidt
14:23
ASCO 2022 Conference Coverage
ASCO 2022 Impact of Trilaciclib on Multilineage Chemo-Induced Myelos…
Feat.
J. Goldschmidt
04:31
ASCO 2022 Conference Coverage
ASCO 2022 Predictors of Biomarker Testing Among Pts With mNSCLC
Feat.
N. Robert
06:43
ASCO 2022 Conference Coverage
ASCO 2022 on a Phase I, Open-Label, Dose Escalation, Confirmation, a…
Feat.
J. Heymach
01:17
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on a Phase I, Open-Label, Dose Escalatio…
Feat.
J. Heymach
20:37
Jia Luo
Taking on Goliath: Targeting KRAS in NSCLC
07:03
ASCO 2022 Conference Coverage
ASCO 2022 on Phase 3 ATLANTIS Trial: Analysis of Patients With Relap…
Feat.
A. Navarro
05:27
ASCO 2022 Conference Coverage
ASCO 2022 on Telisotuzumab Vedotin in Advanced c-Met Overexpressing …
Feat.
R. Camidge
52
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC …
Feat.
A. Navarro
23
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Telisotuzumab Vedotin in Advanced c-M…
Feat.
R. Camidge
05:57
ASCO 2022 Conference Coverage
ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Ad…
Feat.
B. Levy
01:18
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…
Feat.
B. Besse
33
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Combi-TED: A Multicenter Phase II Trial …
Feat.
F. Cappuzzo
04:36
ASCO 2022 Conference Coverage
ASCO 2022 Combi-TED: A Multicenter Phase II Trial Evaluating Efficac…
Feat.
F. Cappuzzo
01:01
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in…
Feat.
K. Gaebe
15:49
ASCO 2022 Conference Coverage
ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in SCLC and Intracra…
Feat.
K. Gaebe
25
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Stud…
Feat.
J. Sands
04:05
ASCO 2022 Conference Coverage
ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolim…
Feat.
J. Sands
24
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …
Feat.
J. Sands
07:37
ASCO 2022 Conference Coverage
ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…
Feat.
J. Sands
52
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Three-Year Outcomes and Correlative Anal…
Feat.
B. Ricciuti
07:54
ASCO 2022 Conference Coverage
ASCO 2022 Three-Year Outcomes and Correlative Analyses in Patients W…
Feat.
B. Ricciuti
07:00
ASCO 2022 Conference Coverage
ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib i…
Feat.
J. Lee
